Processa Pharmaceuticals Inc (PCSA)

Apr 13, 2026

Institution Moves: Is Processa Pharmaceuticals Inc impacted by rising rates2026 Price Targets & Verified Stock Trade Ideas - baoquankhu1.vn

Apr 13, 2026

Apr 11, 2026

Market Recap: What are the risks of holding Processa Pharmaceuticals IncMarket Activity Recap & Safe Investment Capital Preservation Plans - baoquankhu1.vn

Apr 11, 2026

Apr 08, 2026

Nasdaq Moves: Will Processa Pharmaceuticals Inc benefit from current market trendsPortfolio Profit Report & Safe Entry Point Alerts - baoquankhu1.vn

Apr 08, 2026

Apr 07, 2026

Weekly Recap: What is the implied volatility of Processa Pharmaceuticals Inc2026 Chart Watch & High Conviction Buy Zone Picks - baoquankhu1.vn

Apr 07, 2026

Apr 07, 2026

Market Outlook: Is Processa Pharmaceuticals Inc forming higher highs and higher lows2026 Performance Recap & Technical Pattern Recognition Alerts - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026

Whale Trades: Is Processa Pharmaceuticals Inc impacted by rising ratesGDP Growth & Expert Verified Stock Movement Alerts - baoquankhu1.vn

Apr 06, 2026

Apr 04, 2026

Heatwurx (NASDAQ:PCSA) versus Aquestive Therapeutics (NASDAQ:AQST) Critical Review - Defense World

Apr 04, 2026

Apr 02, 2026

Insider Buying: James Neal Acquires Shares of Processa Pharmaceu - GuruFocus

Apr 02, 2026

Apr 02, 2026

Processa Pharmaceuticals Insiders Increase Stock Holdings - Intellectia AI

Apr 02, 2026

Apr 02, 2026

Director Neal James R adds Processa (PCSA) shares in open trade - Stock Titan

Apr 02, 2026

Apr 02, 2026

Processa Pharma chief business officer Lin buys $4063 in PCSA By Investing.com - Investing.com India

Apr 02, 2026

Apr 01, 2026

Insider Buying: Russell Skibsted Acquires Shares of Processa Pha - GuruFocus

Apr 01, 2026

Apr 01, 2026

Russell Skibsted, CFO, buys Processa Pharma (PCSA) shares worth $5,891 - Investing.com UK

Apr 01, 2026

Apr 01, 2026

Russell Skibsted, CFO, buys Processa Pharma (PCSA) shares worth $5,891 By Investing.com - za.investing.com

Apr 01, 2026

Apr 01, 2026

Young David, processa pharma pres, buys PCSA shares worth $4588 - Investing.com

Apr 01, 2026

Apr 01, 2026

Processa Pharma director Pannu buys $5,252 in PCSA stock - Investing.com UK

Apr 01, 2026

Apr 01, 2026

Processa Pharma director Pannu buys $5,252 in PCSA stock By Investing.com - Investing.com Australia

Apr 01, 2026

Apr 01, 2026

Young David, processa pharma pres, buys PCSA shares worth $4588 By Investing.com - Investing.com Canada

Apr 01, 2026

Apr 01, 2026

Ng George K, Processa Pharma CEO, buys PCSA stock worth $5414 - Investing.com Canada

Apr 01, 2026

Apr 01, 2026

Baluch Khoso buys Processa Pharmaceuticals (PCSA) shares worth $5751 By Investing.com - Investing.com South Africa

Apr 01, 2026

Apr 01, 2026

Processa Pharmaceuticals (PCSA) R&D head adds 1,810 shares in open-market buy - Stock Titan

Apr 01, 2026

Apr 01, 2026

Processa Pharmaceuticals (NASDAQ: PCSA) CFO buys 2,324 company shares - Stock Titan

Apr 01, 2026

Apr 01, 2026

Director Geraldine Pannu buys 2,072 Processa (PCSA) shares in market - Stock Titan

Apr 01, 2026

Apr 01, 2026

[Form 4] Processa Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan

Apr 01, 2026

Apr 01, 2026

Baluch Khoso buys Processa Pharmaceuticals (PCSA) shares worth $5751 - Investing.com

Apr 01, 2026

Apr 01, 2026

Processa Pharmaceuticals (PCSA) officer adds 1,603-share open-market buy - Stock Titan

Apr 01, 2026

Apr 01, 2026

Processa Pharmaceuticals (PCSA) CAO buys 1,854 shares in open trade - Stock Titan

Apr 01, 2026

Apr 01, 2026

Processa (NASDAQ: PCSA) CDO buys 2,107 shares in open-market trade - Stock Titan

Apr 01, 2026

Apr 01, 2026

Director adds 2,269 Processa (PCSA) shares at $2.535 each - Stock Titan

Apr 01, 2026

Mar 31, 2026

Processa Pharmaceuticals, Inc.Common Stock (NQ: PCSA - The Chronicle-Journal

Mar 31, 2026

Mar 31, 2026

Weekly Earnings: Should I hold or sell Processa Pharmaceuticals Inc now2026 Volume & Verified Chart Pattern Trade Signals - baoquankhu1.vn

Mar 31, 2026

Mar 31, 2026

PCSA Stock Price, Quote & Chart | PROCESSA PHARMACEUTICALS INC (NASDAQ:PCSA) - ChartMill

Mar 31, 2026

Mar 29, 2026

Aug PreEarnings: What is Processa Pharmaceuticals Incs valuation compared to sector2026 Trading Recap & Free Weekly Watchlist of Top Performers - baoquankhu1.vn

Mar 29, 2026

Mar 26, 2026

PCSA PE Ratio & Valuation, Is PCSA Overvalued - Intellectia AI

Mar 26, 2026

Mar 25, 2026

Trading Recap: Does Processa Pharmaceuticals Inc have a sustainable dividend2026 Final Week & Growth Focused Stock Pick Reports - baoquankhu1.vn

Mar 25, 2026

Mar 25, 2026

Earnings Recap: Does Processa Pharmaceuticals Inc have strong fundamentalsRate Hike & Weekly Consistent Profit Watchlists - baoquankhu1.vn

Mar 25, 2026

Mar 22, 2026

If You Invested $1,000 in Processa Pharmaceuticals Inc (PCSA) - Stock Titan

Mar 22, 2026

Mar 22, 2026

Processa Pharmaceuticals, Inc.: Fundamental Analysis and Financial Ratings - marketscreener.com

Mar 22, 2026

Mar 20, 2026

Aug Macro: Can Processa Pharmaceuticals Inc maintain sales growthMarket Growth Summary & Daily Price Action Insights - baoquankhu1.vn

Mar 20, 2026

Mar 20, 2026

Processa Pharmaceuticals Inc: Fundamental Analysis and Financial Ratings - marketscreener.com

Mar 20, 2026

Mar 19, 2026

Analyst Calls: What are the risks of holding Processa Pharmaceuticals Inc2026 Institutional & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn

Mar 19, 2026

Mar 19, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Mar 19, 2026

Mar 19, 2026

Processa Pharmaceuticals 2025 Annual Report: Next Generation Cancer Therapies, Regulatory Strategy, Pipeline, and Intellectual Property Overview - Minichart

Mar 19, 2026

Mar 18, 2026

Processa Pharmaceuticals 2025 10-K: $0 revenue, $(10.36) EPS on $(13.56)M net loss - TradingView

Mar 18, 2026

Mar 18, 2026

Processa Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 18, 2026

Mar 18, 2026

[10-K] Processa Pharmaceuticals, I... - Stock Titan

Mar 18, 2026

Mar 17, 2026

Processa Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com

Mar 17, 2026

Mar 16, 2026

Processa Pharmaceuticals Inc expected to post a loss of $1.50 a shareEarnings Preview - tradingview.com

Mar 16, 2026

Mar 15, 2026

Alliance Entertainment and Processa Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Gardner News

Mar 15, 2026

Mar 13, 2026

Growth Recap: Whats Processa Pharmaceuticals Incs historical return2026 Sector Review & Verified Momentum Stock Alerts - baoquankhu1.vn

Mar 13, 2026